No black box warning on record for Baxdela

As of the latest FDA labeling reviewed, Baxdela (DELAFLOXACIN MEGLUMINE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Baxdela medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hypersensitivity Reactions: May occur after first or subsequent doses of BAXDELA. Discontinue BAXDELA at the first sign of a skin rash or any other sign of hypersensitivity. ( 5.6 ) Clostridium difficile -associated diarrhea: Evaluate if diarrhea occurs. ( 5.7 ) 5.1 Disabling and Potentially Irreversible Serious Adverse Reactions Including Tendinitis and Tendon Rupture,

No black box warning on record for Baxdela

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hypersensitivity Reactions: May occur after first or subsequent doses of BAXDELA. Discontinue BAXDELA at the first sign of a skin rash or any other sign of hypersensitivity. ( 5.6 ) Clostridium difficile -associated diarrhea: Evaluate if diarrhea occurs. ( 5.7 ) 5.1 Disabling and Potentially Irreversible Serious Adverse Reactions Including Tendinitis and Tendon Rupture,

Baxdela Black Box Warning

No black box warning on record for Baxdela

Other warnings & precautions

Baxdela Black Box Warning

No black box warning on record for Baxdela

Other warnings & precautions